Comprehensive Stock Comparison
Compare ACM Research, Inc. (ACMR) vs NVIDIA Corporation (NVDA) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | NVDA | 65.5% revenue growth vs ACMR's 40.2% |
| Value | NVDA | Lower P/E (21.9x vs 25.2x), PEG 0.23 vs 0.70 |
| Quality / Margins | NVDA | 55.6% net margin vs ACMR's 13.3% |
| Stability / Safety | NVDA | Beta 1.73 vs ACMR's 1.90, lower leverage |
| Dividends | ACMR | 0.2% yield, 2-year raise streak, vs NVDA's 0.0% |
| Momentum (1Y) | ACMR | +114.6% vs NVDA's +41.9% |
| Efficiency (ROA) | NVDA | 58.1% ROA vs ACMR's 4.2%, ROIC 81.8% vs 13.2% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Valuation efficiency (growth/$)
Defensive / Recession hedge
Business Model
What each company does and how it makes money
ACM Research develops and manufactures single-wafer wet cleaning equipment used in semiconductor manufacturing to improve chip yield and performance. It generates revenue primarily from equipment sales—including its Ultra C brand tools for cleaning, plating, and other wafer processing steps—with service and support contracts providing recurring income. The company's competitive advantage lies in its proprietary cleaning technologies—like space alternated phase shift and timely energized bubble oscillation—which offer superior performance for advanced semiconductor nodes while reducing chemical consumption.
NVIDIA designs and sells graphics processing units (GPUs) and accelerated computing platforms that power artificial intelligence, gaming, and professional visualization applications. The company generates revenue primarily through its Data Center segment — which includes AI chips and systems — accounting for over 70% of sales, supplemented by its Gaming GPU business and professional visualization offerings. NVIDIA's competitive moat stems from its CUDA software ecosystem — which locks developers into its hardware architecture — and its years of architectural leadership in parallel processing for AI workloads.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
NVDA leads in 5 of 6 categories (Financial Metrics, Valuation Metrics). ACMR leads in 1 (Analyst Outlook).
Financial Metrics (TTM)
NVDA is the larger business by revenue, generating $215.9B annually — 245.3x ACMR's $880M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to ACMR's 13.3%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| RevenueTrailing 12 months | $880M | $215.9B |
| EBITDAEarnings before interest/tax | $144M | $133.2B |
| Net IncomeAfter-tax profit | $117M | $120.1B |
| Free Cash FlowCash after capex | -$12M | $96.7B |
| Gross MarginGross profit ÷ Revenue | +46.7% | +71.1% |
| Operating MarginEBIT ÷ Revenue | +14.8% | +60.4% |
| Net MarginNet income ÷ Revenue | +13.3% | +55.6% |
| FCF MarginFCF ÷ Revenue | -1.3% | +44.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +32.0% | +73.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +15.6% | +97.8% |
Valuation Metrics
At 36.2x trailing earnings, NVDA trades at a 1% valuation discount to ACMR's 36.4x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.38x vs ACMR's 1.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| Market CapShares × price | $3.3B | $4.31T |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $4.31T |
| Trailing P/EPrice ÷ TTM EPS | 36.39x | 36.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.19x | 21.88x |
| PEG RatioP/E ÷ EPS growth rate | 1.01x | 0.38x |
| EV / EBITDAEnterprise value multiple | 19.35x | 32.33x |
| Price / SalesMarket cap ÷ Revenue | 4.26x | 19.94x |
| Price / BookPrice ÷ Book value/share | 3.37x | 27.52x |
| Price / FCFMarket cap ÷ FCF | 47.62x | 44.54x |
Profitability & Efficiency
NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $6 for ACMR. NVDA carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACMR's 0.17x. On the Piotroski fundamental quality scale (0–9), ACMR scores 6/9 vs NVDA's 4/9, reflecting solid financial health.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +76.3% |
| ROA (TTM)Return on assets | +4.2% | +58.1% |
| ROICReturn on invested capital | +13.2% | +81.8% |
| ROCEReturn on capital employed | +13.7% | +97.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.17x | 0.07x |
| Net DebtTotal debt minus cash | -$219M | $807M |
| Cash & Equiv.Liquid assets | $407M | $10.6B |
| Total DebtShort + long-term debt | $189M | $11.4B |
| Interest CoverageEBIT ÷ Interest expense | 27.72x | 545.03x |
Total Returns (with DRIP)
A $10,000 investment in NVDA five years ago would be worth $128,116 today (with dividends reinvested), compared to $15,510 for ACMR. Over the past 12 months, ACMR leads with a +114.6% total return vs NVDA's +41.9%. The 3-year compound annual growth rate (CAGR) favors NVDA at 96.9% vs ACMR's 75.1% — a key indicator of consistent wealth creation.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| YTD ReturnYear-to-date | +24.1% | -6.2% |
| 1-Year ReturnPast 12 months | +114.6% | +41.9% |
| 3-Year ReturnCumulative with dividends | +436.4% | +663.5% |
| 5-Year ReturnCumulative with dividends | +55.1% | +1181.2% |
| 10-Year ReturnCumulative with dividends | +2877.5% | +22525.7% |
| CAGR (3Y)Annualised 3-year return | +75.1% | +96.9% |
Risk & Volatility
NVDA is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than ACMR's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 83.5% from its 52-week high vs ACMR's 77.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.90x | 1.73x |
| 52-Week HighHighest price in past year | $71.65 | $212.19 |
| 52-Week LowLowest price in past year | $16.82 | $86.62 |
| % of 52W HighCurrent price vs 52-week peak | +77.7% | +83.5% |
| RSI (14)Momentum oscillator 0–100 | 45.7 | 47.4 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 136.2M |
Analyst Outlook
Wall Street rates ACMR as "Buy" and NVDA as "Buy". Consensus price targets imply 52.9% upside for NVDA (target: $271) vs -28.2% for ACMR (target: $40). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | ACMRACM Research, Inc. | NVDANVIDIA Corporation |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $40.00 | $271.00 |
| # AnalystsCovering analysts | 10 | 79 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +0.0% |
| Dividend StreakConsecutive years of raises | 2 | 2 |
| Dividend / ShareAnnual DPS | $0.10 | $0.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Feb 20 | Feb 26 | Change |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | 100 | 524.64 | +424.6% |
| NVIDIA Corporation (NVDA) | 100 | 2,749.78 | +2649.8% |
NVIDIA Corporation (NVDA) returned +1.2K% over 5 years vs ACM Research, Inc. (ACMR)'s +55%. A $10,000 investment in NVDA 5 years ago would be worth $128,116 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | $37M | $782M | +2042.4% |
| NVIDIA Corporation (NVDA) | $6.9B | $215.9B | +3025.0% |
NVIDIA Corporation's revenue grew from $6.9B (2017) to $215.9B (2026) — a 46.6% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | -0.9% | 13.2% | +1630.7% |
| NVIDIA Corporation (NVDA) | 24.1% | 55.6% | +130.6% |
NVIDIA Corporation's net margin went from 24% (2017) to 56% (2026).
Chart 4P/E Ratio History — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | 30.3 | 9.9 | -67.3% |
| NVIDIA Corporation (NVDA) | 75.6 | 36.2 | -52.1% |
ACM Research, Inc. has traded in a 10x–90x P/E range over 7 years; current trailing P/E is ~36x. NVIDIA Corporation has traded in a 28x–291x P/E range over 10 years; current trailing P/E is ~36x.
Chart 5EPS Growth — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | -0.01 | 1.53 | +21957.1% |
| NVIDIA Corporation (NVDA) | 0.06 | 4.9 | +7556.3% |
NVIDIA Corporation's EPS grew from $0.06 (2017) to $4.90 (2026) — a 62% CAGR.
Chart 6Free Cash Flow — 5 Years
ACM Research, Inc. generated $70M FCF in 2024 (+241% vs 2021). NVIDIA Corporation generated $97B FCF in 2026 (+1960% vs 2021).
ACMR vs NVDA: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ACMR or NVDA a better buy right now?
NVIDIA Corporation (NVDA) offers the better valuation at 36.2x trailing P/E (21.9x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACMR or NVDA?
On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 36.2x versus ACM Research, Inc. at 36.4x. On forward P/E, NVIDIA Corporation is actually cheaper at 21.9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0.23x versus ACM Research, Inc.'s 0.70x — a PEG below 1.0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ACMR or NVDA?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1181%, compared to +55.1% for ACM Research, Inc. (ACMR). A $10,000 investment in NVDA five years ago would be worth approximately $128K today (assuming dividends reinvested). Over 10 years, the gap is even starker: NVDA returned +225.3% versus ACMR's +28.8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACMR or NVDA?
By beta (market sensitivity over 5 years), NVIDIA Corporation (NVDA) is the lower-risk stock at 1.73β versus ACM Research, Inc.'s 1.90β — meaning ACMR is approximately 10% more volatile than NVDA relative to the S&P 500. On balance sheet safety, NVIDIA Corporation (NVDA) carries a lower debt/equity ratio of 7% versus 17% for ACM Research, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — ACMR or NVDA?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.6% net margin versus 13.2% for ACM Research, Inc. — meaning it keeps 55.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60.4% versus 19.3% for ACMR. At the gross margin level — before operating expenses — NVDA leads at 71.1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ACMR or NVDA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential. By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0.23x versus ACM Research, Inc.'s 0.70x. A PEG below 1.0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 21.9x forward P/E versus 25.2x for ACM Research, Inc. — 3.3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVDA: 52.9% to $271.00.
07Which pays a better dividend — ACMR or NVDA?
In this comparison, ACMR (0.2% yield) pays a dividend. NVDA does not pay a meaningful dividend and should not be held primarily for income.
08Is ACMR or NVDA better for a retirement portfolio?
For long-horizon retirement investors, NVIDIA Corporation (NVDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+225.3% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 1.90 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NVDA: +225.3%, ACMR: +28.8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ACMR and NVDA?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.